Literature DB >> 31594762

GSK recalls ranitidine products over potential carcinogen contamination.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2019        PMID： 31594762     DOI： 10.1136/bmj.l5933

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018.

Authors:  Masao Iwagami; Ryosuke Kumazawa; Yoshihisa Miyamoto; Yuri Ito; Miho Ishimaru; Kojiro Morita; Shota Hamada; Nanako Tamiya; Hideo Yasunaga
Journal:  Drug Saf       Date:  2020-11-27       Impact factor: 5.606

2.  Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM].

Authors:  Angharad G Davis; Sean Wasserman; Mpumi Maxebengula; Cari Stek; Marise Bremer; Remy Daroowala; Saalikha Aziz; Rene Goliath; Stephani Stegmann; Sonya Koekemoer; Amanda Jackson; Louise Lai Sai; Yakub Kadernani; Thandi Sihoyiya; C Jason Liang; Lori Dodd; Paolo Denti; Thomas Crede; Jonathan Naude; Patryk Szymanski; Yakoob Vallie; Ismail Banderker; Shiraz Moosa; Peter Raubenheimer; Rachel P J Lai; John Joska; Sam Nightingale; Anna Dreyer; Gerda Wahl; Curtis Offiah; Isak Vorster; Sally Candy; Frances Robertson; Ernesta Meintjes; Gary Maartens; John Black; Graeme Meintjes; Robert J Wilkinson
Journal:  Wellcome Open Res       Date:  2021-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.